The buyout, which includes up to $2.15 billion in milestones, will give Bayer control of an eye disease implant that Perfuse ...

If approved, the deal’s centrepiece, PER-001, could continue Bayer’s ophthalmology legacy defined by blockbuster retinal ...

Bayer has agreed terms for its first biopharma acquisition in years, paying $300 million upfront for privately-held US ...

A California study found one in six MIs in younger adults were tied to meth use, many of them with nonobstructive CAD.

Immusoft of CA, a clinical-stage biotechnology company pioneering engineered B cell therapies, today announced that Scott McIvor, Chief Development Officer at Immusoft, will present recent clinical ...

Perfuse Therapeutics’ investigational lead program shows potential to become one of the first disease-modifying treatments for both Glaucoma and Diabetic Retinopathy (DR)High unmet medical need of ...

Bayer to acquire biopharma company Perfuse Therapeutics in up to $2.45 billion deal: Berlin, Germany Bayer, a global enterprise with core co ...

Swedish registry follow-up of >5.3 million pre-pandemic and >5.5 million pandemic adults linked death of a partner, child, ...

Support this channel by checking our NordVPN exclusive deal at <a ...

Cancer patients who experience a recent financial hardship have an increased likelihood of spending more on health care at the end of life.

The longitudinal assessment of albuminuria appears critical for assessing MACE risk in patients with and without CKD. The ...

The death of Massachusetts State Police Trooper Kevin Trainor in Wednesday's head-on crash on Route 1 is a "tragic" wake-up call for Beacon Hill to take immediate steps to prevent ...